MAPT and Alzheimer disease: Lastly, TRIM67, which was discussed above, was also found to be interacting with MAPT and HSP90AA1 in the upregulated subnetwork of cluster 3, and the way that it appears in both up and downregulated subnetworks might strengthen its potential to involve in A1 phenotype to modulate AD pathology.